FDA-Approved Ketamine Therapy

Serving Edmonds, Lynnwood & Shoreline in King & Snohomish Counties

Spravato (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression. Dr. Delaney administers Spravato in a supervised clinical setting, as required by the FDA Risk Evaluation and Mitigation Strategy (REMS) program. Treatment sessions are done in-office, and patients are monitored for at least two hours following each dose.

About Spravato

Spravato works differently from traditional antidepressants. Rather than targeting serotonin or dopamine pathways, esketamine acts on glutamate receptors in the brain and can produce improvements in depressive symptoms faster than oral antidepressants — sometimes within days of the first treatment. It’s prescribed alongside an oral antidepressant, not as a standalone treatment. Dr. Delaney works with patients and their mental health providers to ensure Spravato is part of a coordinated care plan.

Our Ketamine Assisted Therapy Process

Why Patients Choose Our Practice

Who Is a Candidate?

Frequently Asked Questions on Ketamine Therapy

Is Spravato the same as ketamine infusion therapy?

Spravato (esketamine) is a nasal spray version of a ketamine-derived compound, FDA-approved specifically for treatment-resistant depression. Ketamine infusions are IV-administered and used off-label. Spravato has a defined clinical protocol and is covered by many insurance plans.

Does insurance cover Spravato?

Many insurance plans, including Medicare and Medicaid, cover Spravato for patients who meet the clinical criteria. Prior authorization is typically required. The office can assist with the prior authorization process.

Do I need a psychiatrist referral?

If you are already working with a psychiatrist or therapist, that existing relationship is a good starting point. If you are not currently under mental health care, Dr. Delaney can help coordinate appropriate referrals.

Serving Edmonds, Lynnwood & Shoreline